Medicines in Development for Immuno-Oncology 2017 Report
America’s biopharmaceutical research companies are developing more than 240 immuno-oncology treatments.
Interested in reading more on Medicines in Development for Immuno-Oncology 2017 Report?
Get your free copy of the report now.
87%
OF CANCER DIAGNOSES
in the U.S. are people age 50 and older
4.8%+
OF U.S. POPULATION
are cancer survivors
600K
U.S. CANCER DEATHS
were estimated in 2017
1.6M+
NEW CASES OF CANCER
estimated in 2017
